Recent drug approvals for the treatment of relapsed/refractory multiple myeloma
COMy 2017: Day 2 discussion on relapsed myeloma, treatment, plasma cell leukemia and awards
Arnon Nagler et al.
An overview of the current treatment landscape of non-Hodgkin lymphoma
The importance of diagnosing DLBCL on a molecular level and how it will improve treatment
iwNHL 2016: Highlights from Day 1
Catherine Bollard et al.